Skip to main content
. 2017 Jan 26;40(1):66–72. doi: 10.14348/molcells.2017.2259

Fig. 3. Salubrinal (Sal) reduced cardiac hypertrophy.

Fig. 3

(A) Cross sections of hearts under different experimental conditions (scale bar, 2 mm). (B) HW/BW and (C) HW/TL ratios for the various experimental groups (n = 6–8). Salubrinal (Sal) reduced fetal gene expression in TAC induced cardiac hypertrophy. (D and E) Relative mRNA levels of ANP (NPPA), and BNP (NPPB) were evaluated using qRT-PCR (n = 5–6). (F, G) Protein expression levels of ANP and BNP (n = 3–5). All data represent mean ± SEM; *P < 0.05, **P <0.01 vs. Veh SHAM and #P < 0.05, ##P <0.01 vs. Veh TAC.